share_log

Datametrex Announces RSU Grant and Updates Vesting Schedule

Datametrex Announces RSU Grant and Updates Vesting Schedule

Datametrex 宣布 RSU 拨款并更新归属时间表
newsfile ·  02/15 16:30

Toronto, Ontario--(Newsfile Corp. - February 15, 2024) - Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTCQB: DTMXF) (the 'Company' or 'Datametrex') announces that the Board of Directors has approved the grant of an aggregate of 12,500,000 Restricted Share Units ('RSUs') in accordance with the Company's omnibus incentive plan (the 'Plan') to employees, directors, and consultants of the Company. Each RSU entitles the holder to acquire one Common Share on vesting, and the RSUs vest 12 months from the date of grant. The Plan was approved by the shareholders of the Company at the Annual and Special Meeting Shareholders on December 14, 2023.

安大略省多伦多--(Newsfile Corp.-2024 年 2 月 15 日)- Datametrex AI Limited(多伦多证券交易所股票代码:DM)(FSE:D4G)(OTCQB:DTMXF) '公司' 要么 'Datametrex') 宣布董事会已批准授予总计12,500,000个限制性股票单位('RSU') 根据公司的综合激励计划('计划') 致公司的员工、董事和顾问。每个 RSU 赋予持有人在归属时收购一股普通股的权利,RSU 自授予之日起 12 个月归属。该计划于2023年12月14日在年度和特别股东大会上获得公司股东的批准。

Additionally, the Company clarifies vesting in respect of 22,100,000 RSUs granted and announced on January 29, 2024.

此外,公司澄清了2024年1月29日授予并宣布的22,100,000个限制性股票单位的归属情况。

The Company's January 29, 2024 announcement indicated that the 22,100,000 RSUs granted would vest 50% immediately and 50% on April 15, 2024. In accordance with TSXV policies, the RSU will vest 12 months from the date of grant, aligning the vesting schedule more closely with the objectives of the Plan.

该公司于2024年1月29日发布的公告显示,授予的22,100,000个限制性股票单位将立即归属50%,并在2024年4月15日归属50%。根据多伦多证券交易所的政策,RSU将自拨款之日起赋予12个月,使归属时间表与计划的目标更加一致。

About Datametrex

关于 Datametrex

Datametrex is an innovative leader in Technology Solutions, Artificial Intelligence, and Healthcare. The Company excels in delivering tools and solutions that enhance operational efficiencies and business outcomes on a global scale. For more on Datametrex, please visit the company's website.

Datametrex 是技术解决方案、人工智能和医疗保健领域的创新领导者。该公司擅长提供可在全球范围内提高运营效率和业务成果的工具和解决方案。有关Datametrex的更多信息,请访问该公司的网站。

Investor Relations

投资者关系

Charles Park, CFA
Chief Executive Officer & Director
cpark@datametrex.com
(416) 901-5611 x203

查尔斯·帕克,CFA
首席执行官兼董事
cpark@datametrex.com
(416) 901-5611 x203

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

多伦多证券交易所风险投资交易所及其监管服务提供商(该术语在多伦多证券交易所风险交易所的政策中定义)均不对本新闻稿的充分性或准确性承担责任。

Forward-Looking Statements

前瞻性陈述

All statements in this press release that address activities, events, or developments that the Company expects, believes, or anticipates will or may occur in the future are forward-looking statements, including but not limited to the proposed spin-out transaction. These forward-looking statements involve numerous assumptions made by the Company based on its experience, perception of historical trends, current conditions, expected future developments, and other factors it believes are appropriate in the circumstances. In addition, these statements involve substantial known and unknown risks and uncertainties that contribute to the possibility that the predictions, forecasts, projections, and other forward-looking statements will prove inaccurate, certain of which are beyond the Company's control. Except as required by law, the Company does not undertake to revise or update these forward-looking statements after the date hereof or revise them to reflect the occurrence of future unanticipated events.

本新闻稿中所有涉及公司预期、认为或预期未来将或可能发生的活动、事件或发展的声明均为前瞻性陈述,包括但不限于拟议的分拆交易。这些前瞻性陈述涉及公司根据其经验、对历史趋势的看法、当前状况、预期的未来发展以及其认为适合具体情况的其他因素做出的许多假设。此外,这些陈述涉及大量已知和未知的风险和不确定性,这些风险和不确定性使得预测、预测、预测和其他前瞻性陈述有可能被证明不准确,其中一些是公司无法控制的。除非法律要求,否则公司不承诺在本声明发布之日之后修改或更新这些前瞻性陈述,也不会对其进行修改以反映未来意外事件的发生。

###

###

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发